Mortality among oral contraceptive users : 20 year follow up of women in a cohort studyVESSEY, M. P; VILLARD-MACKINTOSH, L; MCPHERSON, K et al.British medical journal (1857). 1989, Vol 299, Num 6714, pp 1487-1491, issn 0007-1447, 5 p.Article

Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hoursELLERTSON, Charlotte; EVANS, Margaret; FERDEN, Sue et al.Obstetrics and gynecology (New York. 1953). 2003, Vol 101, Num 6, pp 1168-1171, issn 0029-7844, 4 p.Article

The Power of the PillMISHELL, Daniel R; WESTHOFF, Carolyn L.Contraception (Stoneham). 1999, Vol 59, Num 1, issn 0010-7824, 43 p., SUPConference Proceedings

Randomised clinical trial to determine optimum initiation time of norgestrel-progestin only contraception in Eldoret Teaching Hospital, KenyaWERE, E. O; KENDALL, J. Z; NYONGESA, P et al.East African medical journal. 1997, Vol 74, Num 2, pp 103-107, issn 0012-835XArticle

Etude de l'activité contraceptive d'une pilule minidosée lors de son utilisation correcte ou incorrecteVALLON, A. M; CRISTOL, P; HEDON, B et al.Contraception, fertilité, sexualité (1991). 1992, Vol 20, Num 5, pp 521-529, issn 1157-8181Article

Postmenopausal hormone-replacement therapyMARTIN, K. A; FREEMAN, M. W.The New England journal of medicine. 1993, Vol 328, Num 15, pp 1115-1117, issn 0028-4793Article

Pathologie veineuse sous oestroprogestatifs = Venous pathology with estroprogestagensVIN, F; ALLAERT, F. A; LEVARDON, M et al.Phlébologie. 1989, Vol 42, Num 3, pp 473-480, issn 0031-8280, 8 p.Article

Justifications cliniques et biologiques de l'emploi de Triella = Clinical and biological justifications of the use of TriellaMCGUIRE, J. L; PASQUALE, S. A; CASTAIGNE, J. P et al.Revue française de gynécologie et d'obstétrique. 1986, Vol 81, Num 12, pp 731-736, issn 0035-290XArticle

Contraception oestro-progestative vaginale = Oestrogen-progestogen contraception per vaginumCOUTINHO, E.Actualités gynécologiques (Paris. 1971). 1986, Vol 17, pp 135-140, issn 0223-4661Article

Contraceptions difficiles : Contraception = Difficult contraceptionsBRICAIRE, Claire; PLU-BUREAU, Geneviève.La Revue du praticien (Paris). 2008, Vol 58, Num 1, issn 0035-2640, 55-58, 61-64 [8 p.]Article

Prescribing and managing oral contraceptive pills and emergency contraception for adolescentsGOLD, M. A.The Pediatric clinics of North America. 1999, Vol 46, Num 4, pp 695-718, issn 0031-3955Article

Contraceptive methods : Potential for abuseBENAGIANO, G; COTTINGHAM, J.International journal of gynaecology and obstetrics. 1997, Vol 56, Num 1, pp 39-46, issn 0020-7292Article

Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiolARCHER, D. F; TIMMER, C. J; LAMMERS, P et al.Fertility and sterility. 1994, Vol 61, Num 4, pp 645-651, issn 0015-0282Article

Jusqu'à quel âge peut-on prescrire la contraception estro-progestative ? = Up to what age can we prescribe oestroprogestative contraceptionGASQ, M; CHINCHILLA, A.-M; COBIN, L et al.Gazette médicale (Paris). 1993, Vol 100, Num 19, pp 20-22, issn 0760-758XArticle

The 3-keto-desogestrel/ethinylestradiol ring : a new parenteral form of hormonal contraceptionSCHINDLER, A. E.European journal of obstetrics, gynecology, and reproductive biology. 1993, Vol 49, Num 1-2, pp 13-14, issn 0301-2115Conference Paper

Œstrogènes et foie = Estragenes and liver diseaseHECHT, Y; BALLADUR, P; DEUTSCH, J.-P et al.Gazette médicale (Paris). 1992, Vol 99, Num 14, pp 21-31, issn 0760-758X, 10 p.Article

The efficacy and tolerability of norgestimate/ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol) : results of an open, multicenter study of 59,701 womenRUNNEBAUM, B; GRUNWALD, K; RABE, T et al.American journal of obstetrics and gynecology. 1992, Vol 166, Num 6, pp 1963-1968, issn 0002-9378, 2Article

Clinical and metabolic effects of a pill containing 30 mcg ethinylestradiol plus 75 mcg gestodeneFIORETTI, P; FRUZZETTI, F; NAVALESI, R et al.Contraception (Stoneham). 1989, Vol 40, Num 6, pp 649-663, issn 0010-7824, 15 p.Article

Cilest^® ouvre une ère nouvelle de contraception = Cilest^®: a new age in contraceptionESPRIT, P.Lyon Méditerranée médical. Médecine du sud-est. 1989, Vol 25, Num 7-8, pp 12396-12398, issn 0766-5466, 3 p.Article

Oral Contraceptives : Mechanism of Action, Dosing, Safety, and EfficacySONDHEIMER, Steven J.Cutis (New York, NY). 2008, Vol 81, Num 1S, pp 19-22, issn 0011-4162, 4 p., SUPArticle

Gynécologie: Quoi de neuf dans le domaine de la contraception ? = Family planning : what's new ?BLANCHI, P. G; MOVAREKHI, S. M; CAMPANA, A et al.Médecine et hygiène. 2001, Vol 59, Num 2330, pp 108-109, issn 0025-6749Article

Oral contraceptives and hormone replacement therapy : IntroductionBURN, I.Journal of nutritional & environmental medicine. 1998, Vol 8, Num 2, pp 103-104, issn 1359-0847Conference Paper

The safety of oral contraceptives : epidemiologic insights from the first 30 yearsGRIMES, D. A.American journal of obstetrics and gynecology. 1992, Vol 166, Num 6, pp 1950-1954, issn 0002-9378, 2Article

Contraception estroprogestative et dyslipidémie : Contraception : mise au point sur les nouveautés et les difficultés = Hormonal contraception and dyslipidemiaDEMERLE-ROUX, C.La Lettre du gynécologue. 2005, Num 300, pp 32-35, issn 0759-1594, 4 p.Article

30 ans de liberté. Pourquoi ? Pour qui ? = Thirty years of freedom. Why? For who?PASINI, W.Reproduction humaine et hormones. 1999, Vol 12, Num 4, pp 384-386, issn 0994-3919Conference Paper